Tower Research Capital (TRC)’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History
Bought
Maintained
Sold
Other funds holding IVOG
RJFSA
SCM
Tower Research Capital (TRC)'s IVOG Position: Q4 2022 in Review
Tower Research Capital (TRC) sold out of Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) in Q4 2022, closing a stake of 3,048 shares — an estimated $240K sold.
Tower Research Capital (TRC) first reported a position in IVOG in Q1 2016 and held it in 16 quarters. The position peaked at $1.46M in Q3 2018. 102 funds tracked by Wall St. Rank hold IVOG as of Q4 2022.
- Tower Research Capital (TRC) reported no remaining Vanguard S&P Mid-Cap 400 Growth ETF position as of Q4 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 3,048 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q4 2022, an estimated $240K.
- Tower Research Capital (TRC) first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q1 2016 and held it in 16 quarters.
- Tower Research Capital (TRC)'s Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $1.46M in Q3 2018.
- 102 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q4 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.